Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05446389 · ClinicalTrials.gov registry record · NA
PAL to Improve Oral Feeding for Infants With Chronic Lung Disease
A NA study, sponsored by University of Missouri-Columbia.
- Terminated
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT05446389 is a NA study that was terminated before completion, run by University of Missouri-Columbia. The registered enrollment target is 33 participants.
The verdict
NCT05446389, a NA study, was terminated before completion, sponsored by University of Missouri-Columbia.
- TERMINATED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the effects of the Pacifier Activated Lullaby (PAL) intervention on the transition to oral feeding for preterm infants with chronic lung disease and respiratory distress syndrome that require non-invasive respiratory support at 34 weeks PMA. This study will utilize a clinical trial design. Participants will be randomized into two groups. One group will receive the PAL intervention, the other group serving as a no contact control. Participants will be matched based on sex, gestational age at birth, and neurologic injury. Infants in the intervention group will receive two PAL sessions a week until successfully transitioned to \<2L of respiratory support and then receive one PAL session within 24 hours of their first oral feeding attempt.
Interventions
- DEVICE Pacifier Activated Lullaby ®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2022-06-08 |
| Est. Completion | 2025-04-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05446389
The ClinicalTrials.gov registry entry for NCT05446389 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pacifier Activated Lullaby ® is the first listed.
NCT05446389 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05446389 about?
NCT05446389 is a clinical study titled "PAL to Improve Oral Feeding for Infants With Chronic Lung Disease". The purpose of this study is to investigate the effects of the Pacifier Activated Lullaby (PAL) intervention on the transition to oral feeding for preterm infants with chronic lung disease and respiratory distress syndrome that require non-invasive respiratory support at 34 weeks PMA. This study wil...
What is the current status of trial NCT05446389?
This trial is currently terminated. It is a NA study. The enrollment target is 33 participants. The study started on 2022-06-08. Estimated completion is 2025-04-24.
What interventions are being tested in trial NCT05446389?
The interventions under investigation include: Pacifier Activated Lullaby ® (DEVICE).
Who is sponsoring clinical trial NCT05446389?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.